Press Center

Latest news and announcements from Nodes Bio

Press Releases

Nodes Bio Solves Real-Time Biological Network Visualization Challenge

January 31, 2026

Company achieves breakthrough in graph rendering, solving NP-complete computer science problem to enable 12-second generation of publication-quality biological pathway diagrams.

Nodes Bio Founder Reflects on 11-Year Journey from Patent Filing to Commercial Launch

January 31, 2026

John Muirhead-Gould shares the story behind Nodes Bio's transformation from foundational IP to biological network visualization platform.

Nodes Bio Partners with Dublin Economic Development for Ohio Life Sciences Ready Community Initiative

January 30, 2026

The Nodes Bio team met with Dublin Economic Development leadership to discuss anchor tenant role in Ohio Life Sciences readiness application.

Nodes Bio Achieves Paying Customer During Rev1 Ventures Accelerator Program

January 26, 2026

Company demonstrates product-market fit with revenue generation while completing Ohio's premier startup accelerator.

Nodes Bio Applies Patent Portfolio to Biological Network Visualization

January 15, 2026

Company leverages existing intellectual property for AI-powered biological pathway analysis and visualization platform.

Media Contact

Company Information

Founded
2025
Headquarters
Columbus, Ohio
Industry
Biotechnology, AI Research Tools
Website
nodes.bio

Leadership

John Muirhead-Gould
Founder
Leading Nodes Bio's mission to make biological network analysis accessible to researchers worldwide.
Christina Muirhead-Gould
Co-Founder
Co-founding Nodes Bio to accelerate scientific discovery through AI-powered visualization tools.
Dr. Patrick Sewell
Board Member
Providing strategic guidance and scientific expertise to advance Nodes Bio's research platform.
Doug Blair
Chief of AI EMR
Former President of the Electronic Medical Records Association. Leading EMR integration strategy and healthcare partnerships.
Evan Muirhead-Gould
Sales Development Representative
Leading researcher outreach to NIH-funded labs at Harvard, Yale, Duke, Biogen, and Broad Institute.